Difference between revisions of "NM Coordinating Committee"
Jump to navigation
Jump to search
m |
|||
| Line 19: | Line 19: | ||
==Meetings== | ==Meetings== | ||
| − | * Tcons are held Quarterly. Contact | + | * Tcons are held Quarterly. Contact RSNA Staff for details. |
Revision as of 16:41, 9 July 2019
- Chairs: Richard Wahl, MD (Co-chair), Anne Smith, PhD (Co-chair), P. David Mozley, MD (Vice-chair)
- RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee coordinates Biomarker Committees based on NM.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page coming soon]
- I-123 Biomarker Committee [page coming soon]
Meetings
- Tcons are held Quarterly. Contact RSNA Staff for details.